Index -
P/E -
EPS (ttm) -1.14
Insider Own 1.04%
Shs Outstand 181.36M
Perf Week -12.98%
Market Cap 11.52B
Forward P/E 529.53
EPS next Y 0.12
Insider Trans -5.34%
Shs Float 179.65M
Perf Month 2.55%
Income -204.15M
PEG -
EPS next Q -0.48
Inst Own 90.03%
Short Float 3.53%
Perf Quarter -2.64%
Sales 2.50B
P/S 4.61
EPS this Y 19.60%
Inst Trans -1.74%
Short Ratio 2.64
Perf Half Y -7.40%
Book/sh 17.34
P/B 3.66
EPS next Y 113.19%
ROA -3.00%
Short Interest 6.34M
Perf Year -2.94%
Cash/sh 4.28
P/C 14.82
EPS next 5Y -
ROE -6.60%
52W Range 56.05 - 100.77
Perf YTD -14.19%
Dividend Est. -
P/FCF 360.90
EPS past 5Y 4.59%
ROI -3.63%
52W High -37.01%
Beta 1.24
Dividend TTM -
Quick Ratio 2.07
Sales past 5Y 43.88%
Gross Margin 70.14%
52W Low 13.26%
ATR (14) 3.31
Dividend Ex-Date -
Current Ratio 2.32
EPS Y/Y TTM 67.92%
Oper. Margin -12.20%
RSI (14) 42.53
Volatility 5.66% 4.78%
Employees 6600
Debt/Eq 0.82
Sales Y/Y TTM 19.93%
Profit Margin -8.17%
Recom 1.32
Target Price 89.78
Option/Short Yes / Yes
LT Debt/Eq 0.79
EPS Q/Q 61.80%
Payout -
Rel Volume 0.66
Prev Close 63.22
Sales Surprise 1.26%
EPS Surprise 36.16%
Sales Q/Q 16.98%
Earnings May 08 AMC
Avg Volume 2.40M
Price 63.48
SMA20 -6.99%
SMA50 0.33%
SMA200 -10.88%
Trades
Volume 1,597,901
Change 0.41%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-02-24 Upgrade
The Benchmark Company
Hold → Buy
$91
Dec-14-23 Initiated
Guggenheim
Buy
$90
Dec-13-23 Initiated
Wolfe Research
Outperform
$95
Oct-10-23 Upgrade
Piper Sandler
Neutral → Overweight
$90
Sep-28-23 Initiated
Bernstein
Outperform
$83
Aug-02-23 Downgrade
The Benchmark Company
Buy → Hold
May-10-23 Upgrade
Craig Hallum
Hold → Buy
$55 → $85
May-05-23 Initiated
UBS
Neutral
$73
Mar-09-23 Upgrade
Citigroup
Neutral → Buy
$70 → $90
Feb-10-23 Downgrade
Credit Suisse
Outperform → Neutral
$50 → $70
Jan-18-23 Downgrade
Raymond James
Outperform → Mkt Perform
Oct-19-22 Downgrade
Craig Hallum
Buy → Hold
$60 → $35
Aug-25-22 Initiated
Credit Suisse
Outperform
$55
Jun-03-22 Initiated
Piper Sandler
Neutral
$50
Nov-03-21 Downgrade
Raymond James
Strong Buy → Outperform
$160 → $130
Jul-29-21 Reiterated
Stifel
Buy
$165 → $145
Jul-29-21 Reiterated
Oppenheimer
Outperform
$161 → $155
Jul-29-21 Reiterated
Canaccord Genuity
Buy
$185 → $160
Jul-29-21 Reiterated
BTIG Research
Buy
$155 → $145
Jun-15-21 Initiated
Raymond James
Strong Buy
$160
Show Previous Ratings
Apr-17-24 06:15PM
Apr-15-24 06:52AM
06:00AM
Apr-12-24 07:00AM
06:49AM
06:40AM
Loading…
06:40AM
Apr-11-24 06:00AM
Apr-10-24 06:15PM
08:16AM
12:00AM
Apr-09-24 07:37AM
Apr-08-24 12:05PM
07:00AM
(The Wall Street Journal)
06:00AM
Apr-05-24 10:16AM
10:15AM
Loading…
Apr-04-24 10:15AM
06:05AM
Apr-03-24 09:57AM
Apr-02-24 04:02PM
(Investor's Business Daily)
Mar-29-24 08:09AM
Mar-28-24 06:00AM
Mar-27-24 08:05AM
Mar-26-24 07:00AM
Mar-25-24 09:55AM
Mar-22-24 11:30AM
Mar-18-24 08:19AM
04:30AM
Mar-14-24 04:16PM
(Investor's Business Daily)
Mar-13-24 05:03PM
Mar-11-24 12:59AM
09:55AM
Loading…
Mar-08-24 09:55AM
Mar-07-24 07:59AM
Mar-04-24 11:52PM
03:49PM
10:38AM
Mar-03-24 10:32AM
Feb-26-24 06:00AM
Feb-23-24 12:01PM
Feb-22-24 11:08AM
10:30AM
(Thomson Reuters StreetEvents)
10:22AM
01:30AM
12:06AM
Feb-21-24 06:20PM
05:41PM
(Associated Press Finance)
05:12PM
04:05PM
Feb-20-24 02:39AM
Feb-15-24 07:47AM
Feb-14-24 10:00AM
Feb-13-24 08:12PM
Feb-10-24 05:06PM
Feb-07-24 09:00AM
Feb-01-24 06:00AM
Jan-28-24 09:25AM
Jan-22-24 08:00AM
Jan-18-24 05:04AM
Jan-13-24 02:05PM
Jan-08-24 02:48PM
Jan-07-24 04:30PM
Jan-02-24 06:00AM
Dec-21-23 09:43AM
Dec-20-23 01:49PM
Dec-17-23 05:43AM
Dec-14-23 04:02AM
Dec-13-23 12:52PM
08:45AM
Dec-07-23 08:05AM
Dec-05-23 09:11AM
Dec-04-23 12:13PM
Dec-01-23 11:32AM
05:26AM
Nov-30-23 04:05PM
Nov-25-23 09:45AM
Nov-23-23 12:02PM
Nov-20-23 03:06PM
09:55AM
07:30AM
Nov-17-23 08:04PM
(Morningstar Research) +8.39%
07:10AM
Nov-14-23 05:20AM
Nov-10-23 07:00AM
Nov-09-23 08:10PM
(Morningstar Research) -5.09%
Nov-06-23 09:35AM
Nov-03-23 08:09PM
(Morningstar Research) +7.30%
Nov-02-23 07:23PM
04:02PM
(Investor's Business Daily)
11:03AM
09:40AM
(Thomson Reuters StreetEvents)
01:14AM
12:30AM
Nov-01-23 06:06PM
04:05PM
06:00AM
Oct-31-23 05:20PM
11:25AM
Oct-30-23 10:20PM
Oct-27-23 08:11PM
Oct-26-23 10:02AM
Oct-25-23 10:02AM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Baranick Brian EVP, GM., Precision Oncology Apr 02 '24 Sale 79.43 924 73,393 13,171 Apr 03 07:30 PM Condella Sarah EVP, Human Resources Apr 01 '24 Sale 70.00 2,000 140,000 71,787 Apr 03 07:30 PM Condella Sarah EVP, Human Resources Mar 28 '24 Sale 70.00 2,000 140,000 73,787 Apr 01 04:30 PM Conroy Kevin T President and CEO Mar 01 '24 Sale 59.32 8,271 490,636 1,299,496 Mar 04 08:38 PM LEVANGIE DANIEL J Director Mar 01 '24 Sale 57.50 5,000 287,500 22,975 Mar 04 08:42 PM Cunningham Everett Chief Commercial Officer Mar 01 '24 Sale 59.32 2,412 143,080 46,179 Mar 04 08:38 PM Elliott Jeffrey Thomas Chief Financial Officer Mar 01 '24 Sale 59.32 2,412 143,080 10,933 Mar 04 08:40 PM Baranick Brian Gen. Mgr., Precision Oncology Mar 01 '24 Sale 59.32 2,323 137,800 14,095 Mar 04 08:36 PM ORVILLE JACOB A General Manager, Screening Mar 01 '24 Sale 59.32 2,154 127,775 14,324 Mar 04 08:42 PM Doyle James Edward Director Mar 01 '24 Sale 57.50 2,000 115,000 50,110 Mar 04 08:39 PM Condella Sarah EVP, Human Resources Mar 01 '24 Sale 59.32 1,724 102,268 75,787 Mar 04 08:37 PM Herriott James General Counsel Mar 01 '24 Sale 59.32 862 51,134 9,125 Mar 04 08:41 PM Herriott James General Counsel Feb 29 '24 Option Exercise 0.00 1,890 0 9,987 Mar 04 08:41 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 29 '24 Option Exercise 0.00 5,291 0 13,345 Mar 04 08:40 PM Cunningham Everett Chief Commercial Officer Feb 29 '24 Option Exercise 0.00 5,291 0 48,591 Mar 04 08:38 PM Conroy Kevin T President and CEO Feb 29 '24 Option Exercise 0.00 18,143 0 1,307,767 Mar 04 08:38 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 29 '24 Option Exercise 0.00 4,724 0 16,418 Mar 04 08:36 PM Condella Sarah EVP, Human Resources Feb 29 '24 Option Exercise 0.00 3,779 0 77,511 Mar 04 08:37 PM ORVILLE JACOB A General Manager, Screening Feb 29 '24 Option Exercise 0.00 4,724 0 16,478 Mar 04 08:42 PM Conroy Kevin T President and CEO Feb 27 '24 Sale 56.89 6,263 356,302 1,289,624 Feb 28 07:35 PM Cunningham Everett Chief Commercial Officer Feb 27 '24 Sale 56.89 3,648 207,535 43,300 Feb 28 07:37 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 27 '24 Sale 56.89 2,710 154,172 8,054 Feb 28 07:36 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 27 '24 Sale 56.89 2,027 115,316 11,694 Feb 28 07:34 PM Condella Sarah EVP, Human Resources Feb 27 '24 Sale 56.89 1,880 106,953 73,732 Feb 28 07:35 PM ORVILLE JACOB A General Manager, Screening Feb 27 '24 Sale 56.89 1,879 106,896 11,754 Feb 28 07:38 PM Herriott James General Counsel Feb 27 '24 Sale 56.89 784 44,602 8,097 Feb 28 07:38 PM ORVILLE JACOB A General Manager, Screening Feb 26 '24 Option Exercise 0.00 3,954 0 13,633 Feb 28 07:38 PM Cunningham Everett Chief Commercial Officer Feb 26 '24 Option Exercise 0.00 7,678 0 46,948 Feb 28 07:37 PM Herriott James General Counsel Feb 26 '24 Option Exercise 0.00 1,648 0 8,881 Feb 28 07:38 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 26 '24 Option Exercise 0.00 5,701 0 10,764 Feb 28 07:36 PM Condella Sarah EVP, Human Resources Feb 26 '24 Option Exercise 0.00 3,954 0 75,612 Feb 28 07:35 PM Conroy Kevin T President and CEO Feb 26 '24 Option Exercise 0.00 13,181 0 1,295,887 Feb 28 07:35 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 26 '24 Option Exercise 0.00 3,954 0 13,721 Feb 28 07:34 PM Conroy Kevin T President and CEO Feb 23 '24 Option Exercise 13.96 102,837 1,435,605 1,344,266 Feb 26 05:00 PM Condella Sarah EVP, Human Resources Feb 23 '24 Sale 59.72 1,021 60,974 71,658 Feb 26 05:00 PM Conroy Kevin T President and CEO Feb 22 '24 Sale 59.78 11,565 691,356 1,241,429 Feb 23 07:59 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 22 '24 Sale 59.78 1,351 80,763 5,063 Feb 23 08:01 PM Cunningham Everett Chief Commercial Officer Feb 22 '24 Sale 59.78 1,350 80,703 39,270 Feb 23 08:00 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 22 '24 Sale 59.78 1,093 65,340 9,767 Feb 23 07:57 PM ORVILLE JACOB A General Manager, Screening Feb 22 '24 Sale 59.78 1,013 60,557 9,679 Feb 23 08:03 PM Condella Sarah EVP, Human Resources Feb 22 '24 Sale 59.78 1,013 60,557 72,679 Feb 23 07:57 PM COWARD D SCOTT Director Feb 22 '24 Sale 59.78 663 39,634 44,493 Feb 23 07:59 PM Herriott James General Counsel Feb 22 '24 Sale 59.78 291 17,396 7,233 Feb 23 08:02 PM Conroy Kevin T President and CEO Feb 21 '24 Sale 61.50 4,975 305,962 1,229,756 Feb 22 07:37 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 21 '24 Sale 61.50 1,493 91,820 3,703 Feb 22 07:38 PM Condella Sarah EVP, Human Resources Feb 21 '24 Sale 61.50 1,079 66,358 71,658 Feb 22 07:36 PM ORVILLE JACOB A General Manager, Screening Feb 21 '24 Sale 61.50 1,078 66,297 8,658 Feb 22 07:40 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 21 '24 Sale 61.50 895 55,042 8,826 Feb 22 07:36 PM COWARD D SCOTT Director Feb 21 '24 Sale 61.50 706 43,419 43,122 Feb 22 07:38 PM Herriott James General Counsel Feb 21 '24 Sale 61.50 415 25,522 6,943 Feb 22 07:39 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 20 '24 Option Exercise 0.00 3,112 0 5,196 Feb 22 07:38 PM Conroy Kevin T President and CEO Feb 20 '24 Option Exercise 0.00 10,374 0 1,234,731 Feb 22 07:37 PM COWARD D SCOTT Director Feb 20 '24 Option Exercise 0.00 2,248 0 43,828 Feb 22 07:38 PM Baranick Brian Gen. Mgr., Precision Oncology Feb 20 '24 Option Exercise 0.00 1,729 0 9,721 Feb 22 07:36 PM Condella Sarah EVP, Human Resources Feb 20 '24 Option Exercise 0.00 2,248 0 72,737 Feb 22 07:36 PM Herriott James General Counsel Feb 20 '24 Option Exercise 0.00 864 0 7,358 Feb 22 07:39 PM ORVILLE JACOB A General Manager, Screening Feb 20 '24 Option Exercise 0.00 2,248 0 9,736 Feb 22 07:40 PM Conroy Kevin T President and CEO Feb 15 '24 Sale 61.43 14,791 908,611 1,224,357 Feb 16 06:22 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 15 '24 Sale 61.43 1,888 115,980 2,084 Feb 16 06:24 PM COWARD D SCOTT Director Feb 15 '24 Sale 61.43 1,376 84,528 41,580 Feb 16 06:23 PM ORVILLE JACOB A General Manager, Screening Feb 15 '24 Sale 61.43 966 59,341 7,488 Feb 16 06:26 PM Condella Sarah EVP, Human Resources Feb 15 '24 Sale 61.43 965 59,280 70,489 Feb 16 06:21 PM Herriott James General Counsel Feb 15 '24 Sale 61.43 421 25,862 6,494 Feb 16 06:25 PM Conroy Kevin T President and CEO Feb 14 '24 Option Exercise 0.00 31,133 0 1,239,148 Feb 16 06:22 PM Condella Sarah EVP, Human Resources Feb 14 '24 Option Exercise 0.00 2,031 0 71,454 Feb 16 06:21 PM Herriott James General Counsel Feb 14 '24 Option Exercise 0.00 883 0 6,915 Feb 16 06:25 PM ORVILLE JACOB A General Manager, Screening Feb 14 '24 Option Exercise 0.00 2,031 0 8,454 Feb 16 06:26 PM Elliott Jeffrey Thomas Chief Financial Officer Feb 14 '24 Option Exercise 0.00 3,972 0 3,972 Feb 16 06:24 PM COWARD D SCOTT Director Feb 14 '24 Option Exercise 0.00 3,972 0 42,956 Feb 16 06:23 PM Condella Sarah EVP, Human Resources Jan 02 '24 Sale 73.50 2,000 147,000 69,423 Jan 04 05:19 PM Baranick Brian Gen. Mgr., Precision Oncology Jan 02 '24 Sale 73.50 879 64,606 7,992 Jan 04 05:17 PM Condella Sarah EVP, Human Resources Dec 14 '23 Sale 70.00 2,000 140,000 71,423 Dec 18 07:49 PM Cunningham Everett Chief Commercial Officer Oct 12 '23 Sale 66.49 13,007 864,835 37,909 Oct 13 07:59 PM Cunningham Everett Chief Commercial Officer Oct 11 '23 Option Exercise 0.00 27,504 0 50,916 Oct 13 07:59 PM Condella Sarah EVP, Human Resources Sep 01 '23 Sale 84.36 4,500 379,620 75,814 Sep 06 04:04 PM Elliott Jeffrey Thomas Chief Financial Officer Aug 21 '23 Sale 82.92 30,210 2,505,013 0 Aug 23 04:08 PM Baranick Brian Gen. Mgr., Precision Oncology Aug 07 '23 Sale 85.04 1,350 114,804 8,871 Aug 08 04:09 PM Baranick Brian Gen. Mgr., Precision Oncology Aug 04 '23 Option Exercise 0.00 2,712 0 10,221 Aug 08 04:09 PM Doyle James Edward Director Jul 27 '23 Sale 97.42 2,000 194,840 52,110 Jul 28 04:06 PM Herriott James General Counsel Jul 19 '23 Sale 100.00 1,300 130,000 5,964 Jul 21 04:04 PM Zanotti Katherine S Director Jun 09 '23 Sale 90.51 3,027 273,974 64,629 Jun 12 04:17 PM Doyle James Edward Director Jun 09 '23 Sale 90.51 1,402 126,895 54,110 Jun 12 04:29 PM Herriott James General Counsel Jun 08 '23 Sale 90.00 1,300 117,000 7,264 Jun 12 04:14 PM Doyle James Edward Director May 26 '23 Sale 80.62 2,000 161,240 51,913 May 31 04:13 PM Condella Sarah EVP, Human Resources May 10 '23 Sale 80.00 6,087 486,960 80,314 May 12 04:11 PM ORVILLE JACOB A General Manager, Screening May 10 '23 Sale 80.00 5,000 400,000 6,423 May 12 04:09 PM Herriott James General Counsel May 10 '23 Sale 79.85 1,300 103,805 8,564 May 12 04:07 PM Condella Sarah EVP, Human Resources May 01 '23 Sale 63.78 1,000 63,780 86,401 May 03 04:04 PM
Index -
P/E -
EPS (ttm) -0.54
Insider Own 0.00%
Shs Outstand 906.40M
Perf Week -3.01%
Market Cap 18.11B
Forward P/E 11.39
EPS next Y 1.75
Insider Trans -
Shs Float 906.39M
Perf Month -3.94%
Income -503.42M
PEG -
EPS next Q 0.30
Inst Own 7.59%
Short Float 0.22%
Perf Quarter -14.54%
Sales 19.64B
P/S 0.92
EPS this Y 11.56%
Inst Trans -26.09%
Short Ratio 1.91
Perf Half Y 5.05%
Book/sh 14.66
P/B 1.36
EPS next Y 17.24%
ROA -1.50%
Short Interest 1.96M
Perf Year 14.62%
Cash/sh 2.28
P/C 8.77
EPS next 5Y 15.56%
ROE -3.59%
52W Range 17.40 - 24.27
Perf YTD -14.36%
Dividend Est. 0.89 (4.44%)
P/FCF 9.34
EPS past 5Y -
ROI -2.39%
52W High -17.68%
Beta 0.86
Dividend TTM -
Quick Ratio 0.78
Sales past 5Y -1.50%
Gross Margin 40.99%
52W Low 14.84%
ATR (14) 0.36
Dividend Ex-Date May 12, 2022
Current Ratio 1.20
EPS Y/Y TTM 69.49%
Oper. Margin 4.44%
RSI (14) 43.56
Volatility 1.58% 1.40%
Employees 69656
Debt/Eq 0.64
Sales Y/Y TTM 5.03%
Profit Margin -2.56%
Recom 3.38
Target Price 22.02
Option/Short Yes / Yes
LT Debt/Eq 0.58
EPS Q/Q -
Payout -
Rel Volume 0.49
Prev Close 20.15
Sales Surprise -
EPS Surprise -
Sales Q/Q 5.04%
Earnings Apr 29 BMO
Avg Volume 1.03M
Price 19.98
SMA20 -1.31%
SMA50 -2.16%
SMA200 -4.89%
Trades
Volume 504,998
Change -0.84%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-07-24 Downgrade
Exane BNP Paribas
Outperform → Underperform
Jul-12-23 Initiated
Goldman
Buy
Jan-17-23 Downgrade
UBS
Neutral → Sell
Oct-18-22 Initiated
Morgan Stanley
Equal-Weight
Oct-14-22 Downgrade
Deutsche Bank
Hold → Sell
Sep-12-22 Upgrade
Societe Generale
Hold → Buy
Sep-06-22 Upgrade
UBS
Sell → Neutral
Jul-25-22 Downgrade
Societe Generale
Buy → Hold
Jun-16-22 Downgrade
UBS
Neutral → Sell
Jan-20-22 Downgrade
Jefferies
Buy → Hold
Jan-14-22 Upgrade
HSBC Securities
Hold → Buy
Jan-12-22 Downgrade
Citigroup
Buy → Neutral
Sep-08-21 Initiated
Jefferies
Buy
Jul-08-21 Downgrade
Deutsche Bank
Buy → Hold
Jun-21-21 Downgrade
HSBC Securities
Buy → Hold
Mar-18-21 Upgrade
JP Morgan
Neutral → Overweight
Jul-28-20 Initiated
Societe Generale
Buy
Jul-30-19 Initiated
Citigroup
Buy
Feb-12-18 Upgrade
Berenberg
Hold → Buy
Nov-09-17 Downgrade
JP Morgan
Overweight → Neutral
Show Previous Ratings
Apr-17-24 07:17AM
Apr-16-24 09:38AM
Apr-10-24 10:51AM
(The Wall Street Journal)
04:57AM
03:00AM
02:05AM
Loading…
02:05AM
Apr-09-24 05:03PM
04:57PM
04:31PM
(Associated Press Finance)
04:19PM
02:29PM
Apr-08-24 10:29AM
Apr-05-24 12:37PM
(The Wall Street Journal)
Apr-04-24 09:00AM
Apr-02-24 09:16AM
04:00AM
Loading…
Mar-22-24 04:00AM
Mar-19-24 05:00AM
Mar-14-24 11:59AM
Mar-13-24 10:18AM
Mar-12-24 11:01AM
09:00AM
08:00AM
Mar-11-24 09:56AM
Mar-06-24 04:00AM
Mar-04-24 08:27AM
Mar-01-24 12:00PM
11:05AM
Feb-29-24 04:00AM
12:04AM
Feb-28-24 09:47AM
04:00AM
Loading…
04:00AM
01:00AM
Feb-27-24 06:00AM
Feb-26-24 09:22AM
Feb-23-24 08:03PM
05:09PM
05:03PM
Feb-20-24 03:00AM
02:30AM
02:30AM
Feb-16-24 10:00AM
(The Wall Street Journal)
Feb-15-24 01:33PM
01:14PM
Feb-06-24 09:44AM
09:00AM
05:49AM
05:49AM
Feb-02-24 10:02AM
Feb-01-24 02:23AM
Jan-31-24 02:29PM
01:51PM
09:00AM
Jan-30-24 12:11PM
08:58AM
03:45AM
(The Wall Street Journal)
Jan-29-24 02:05PM
02:04PM
(Associated Press Finance)
01:42PM
12:46PM
11:55AM
(Investor's Business Daily)
10:55AM
(The Wall Street Journal)
10:50AM
(The Wall Street Journal)
06:40AM
06:01AM
(The Wall Street Journal)
05:18AM
05:06AM
(Associated Press Finance)
01:18AM
01:01AM
01:00AM
Jan-26-24 06:31AM
Jan-25-24 09:38AM
09:01AM
09:00AM
Jan-19-24 09:45AM
Jan-18-24 04:24AM
Dec-22-23 05:53AM
Dec-21-23 11:50PM
11:28AM
05:12AM
Dec-20-23 03:44PM
02:56PM
Dec-19-23 09:30AM
Dec-18-23 09:50AM
Dec-14-23 08:17PM
(Morningstar Research) +5.92%
09:00AM
05:27AM
Dec-12-23 09:00AM
Dec-04-23 01:08PM
(The Wall Street Journal)
Dec-01-23 08:25AM
Nov-30-23 11:32AM
Nov-29-23 09:00PM
10:41AM
09:00AM
05:19AM
03:01AM
Nov-28-23 01:12PM
09:00AM
08:38AM
Nov-27-23 10:27AM
09:00AM
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.
Category Global or ExUS Equities - Broad / Regional
Asset Type Equities (Stocks)
Tags Europe
Return% 1Y 12.45%
Shs Outstand
Perf Week -2.28%
Sponsor State Street (SPDR)
ETF Type
Tags equity
Return% 3Y 5.77%
Total Holdings 53
Perf Month -3.28%
Fund Family
Bond Type
Tags large-cap
Return% 5Y 8.77%
AUM 3.45B
Perf Quarter 8.03%
Index EURO STOXX 50 Index
Average Maturity
Tags -
Return% 10Y
NAV%
Perf Half Y 19.59%
Index Weighting
Commodity Type
Tags -
Return% SI
NAV/sh
Perf Year 8.43%
Active/Passive
Quant Type
Tags -
Flows% 1M 7.89%
52W Range 40.23 - 53.02
Perf YTD 4.96%
Dividend TTM 1.28 (2.55%)
ESG Type
Tags -
Flows% 3M 24.55%
52W High -5.35%
Beta 1.10
Dividend Ex-Date Mar 18, 2024
Dividend Type
Sector/Theme
Flows% YTD 24.55%
52W Low 24.73%
ATR (14) 0.63
Expense 0.29%
Structure Type
Region
Flows% 1Y
RSI (14) 36.61
Volatility 1.32% 0.98%
Option/Short Yes / Yes
Growth/Value
Dev/Emerg
Flows% 3Y
Rel Volume 1.09
Prev Close 50.21
Inverse/Leveraged
Market Cap
Currency
Flows% 5Y
Avg Volume 1.22M
Price 50.18
SMA20 -3.13%
SMA50 -1.54%
SMA200 8.19%
Trades
Volume 1,323,045
Change -0.06%
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite